Method for using tylosin refined solution in fermentation of acetylisovaleryltylosin tartrate
Purified tylosin filtrate by butyl acetate extraction and use it in tylosin fermentation, which solves the problem of insufficient quality of tylosin production, improves fermentation titer and quality, reduces costs, and provides A new method of synergistic production of tyloxin and tyloxin.
Patent Information
- Application Number
- CN202411063923.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2024-11-08
AI Technical Summary
In the existing tevamectin fermentation process, the tevamectin filtrate has not been extracted and purified by butyl acetate, resulting in insufficient components, affecting the production quality of tevamectin and the final tanking level.
The tylosin filtrate was extracted and purified by butyl acetate, and the tylosin refined solution was prepared, and the tylosin refined solution was used in the tylosin fermentation, so as to control the residue of organic solvents within the appropriate concentration range, and improve the fermentation titer.
The final pot titer of tyvonectin has been significantly improved to above 35,000μg/mL, reducing production costs, and improving fermentation quality, providing a new idea of the linkage of tyvonectin and tyvonectin.
Abstract
Description
Technical Field
[0001] The invention relates to the field of microbial fermentation, and in particular to a method for using tylosin refined liquid in tylosin fermentation. Background Art
[0002] Tylvalosin is a third-generation macrolide drug for animals. It can reach the bronchial cavity and kill mycoplasma. It has many advantages such as strong antibacterial activity, high safety, low drug resistance, low residue and no adverse reactions. It has strong antibacterial activity against mycoplasma, spirochetes, most Gram-positive bacteria and some Gram-negative bacteria. It is mainly used clinically for the prevention and treatment of acute and chronic respiratory and digestive tract diseases in animals.
[0003] This type of antibiotic is mainly produced by a microbial fermentation process or a semi-synthetic process. In the microbial fermentation process, the finished product of tylosin is mainly used as a raw material and converted into tylosin in an actinomycete fermentation system. CN 117660573 A discloses a green co-production process of tylosin and tylosin. The method prepares the finished product of tylosin by directly using the filtrate containing tylosin for subsequent actinomycete fermentation conversion to generate tylosin without extracting and purifying the tylosin with butyl acetate and spray drying. This method can not only reduce the production cost, but also avoid the use of organic solvents such as butyl acetate in the preparation of tylosin, reduce environmental pollution, and have high environmental protection. However, this method is not ideal in actual production applications. The tylosin filtrate is not extracted and purified with butyl acetate, and the components of the tylosin filtrate are only about 83-85%, with a content of about 9000-10000 μg / ml, which does not meet the requirements of the tylosin fermentation process, resulting in poor quality of the converted tylosin, which seriously affects the final tank release level of the fermentation. Summary of the invention
[0004] In view of the deficiencies in the above-mentioned prior art, the object of the present invention is to provide a method for using tylosin refined liquid in tylosin fermentation. The present invention first refines the tylosin filtrate purified by butyl acetate extraction to obtain tylosin refined liquid, and then uses the tylosin refined liquid for tylosin fermentation. Not only does it avoid the high cost of using tylosin finished products in tylosin fermentation, but it can also achieve an increase in the fermentation titer of tylosin, and the final potting titer can be increased to more than 35,000 μg / mL. It provides a new idea for the joint production of tylosin and tylosin.
[0005] In order to achieve the above object, the present invention adopts the following technical scheme:
[0006] A method for using tylosin refined liquid in tylosin fermentation comprises the following steps:
[0007] The tylosin refined solution is added to the tylosin fermentation tank, and the preparation method of the tylosin refined solution comprises:
[0008] The intermediate of tylosin finished product, tylosin filtrate, is obtained. After extraction and purification with butyl acetate, the residual organic solvent in the tylosin filtrate is controlled to meet the requirements: 100μg / mL≤butyl acetate residue≤300μg / mL, 200μg / mL≤acetic acid+butanol residue≤500μg / mL, and then sterilized to obtain tylosin refined liquid.
[0009] The method for obtaining tylosin filtrate in the present invention is as follows: after tylosin producing bacteria are subjected to liquid fermentation for 140-200 hours, the pH of the fermentation liquid is adjusted to 3.5-4.5 with acid so that the tylosin in the fermentation liquid becomes a strongly water-soluble tylosin salt, and then the tylosin filtrate is obtained by solid-liquid separation. After the tylosin filtrate is extracted and purified with butyl acetate, the tylosin component reaches more than 90%, and the content reaches more than 200000ug / mL.
[0010] Among them, the 100μg / mL ≤ butyl acetate residue ≤ 300μg / mL, 200μg / mL ≤ acetic acid + butanol residue ≤ 500μg / mL in the tylosin filtrate is controlled, and then sterilized to obtain a tylosin refined solution. The fermentation level of the tylosin fermentation broth obtained after the transformation using the slurry is significantly improved. When the organic solvent residue is within an appropriate concentration range, the organic solvent can increase the permeability of the cell membrane, which is beneficial to the utilization of effective substances in the fermentation broth and product secretion; when the organic solvent residue exceeds a certain concentration, the organic solvent will inhibit the transformation of the tylosin-producing strain or even apoptosis.
[0011] Furthermore, when the nucleic acid content in the fermentation tank reaches above 0.4 g / L, the tylosin refined solution is added to the tylosin fermentation tank by a feeding method, and the flow rate of the tylosin refined solution is adjusted in real time according to the tylosin fermentation level.
[0012] Furthermore, the flow rate was maintained at 5 μg / mL≤butyl acetate residual≤21 μg / mL, and 12 μg / mL≤acetic acid+butanol residual≤35 μg / mL in the fermentation broth.
[0013] By passing sterile air for purging and filtering with an activated carbon filter, the residual organic solvent in the tylosin filtrate can be controlled to meet the requirements. Among them, by passing sterile air for purging, the butyl acetate content in the tylosin filtrate can be controlled to meet the requirements. Specifically, the filtrate temperature is controlled to be maintained at 0-6°C for purging for 3 hours, and then the temperature is raised to 20°C for purging for 3 hours. Among them, by filtering with an activated carbon filter, the total content of acetic acid and butanol in the tylosin filtrate can be controlled to meet the requirements. Specifically, the filtrate temperature is controlled to be maintained at 20°C, and the membrane surface flow rate is 1.5m / s and filtered with an activated carbon filter.
[0014] Among them, the sterilization step is to use membrane filtration or water bath heating, the pore size of the filter membrane is ≤0.22μm, the water bath temperature is ≥80℃, and the insulation time is ≥30 minutes.
[0015] Specifically, a method for using tylosin refined liquid in tylosin fermentation comprises the following steps: S1 shake flask seed culture: inoculating a tylosin-producing strain into a shake flask seed liquid for culture; S2 seed tank culture: inoculating the cultured shake flask seed liquid into a seed tank culture medium for culture; S3 fermentation tank culture: inoculating the cultured seed culture medium in the seed tank into a fermentation tank for culture, culturing until the biomass in the fermentation tank reaches the conversion requirement, adding the tylosin refined liquid to the fermentation tank, replacing the tylosin finished product for conversion in the tylosin strain fermentation, and the final potency of the tylosin fermentation is above 35000 μg / mL.
[0016] The culture conditions of the shaking bottle seeds in step S1 are as follows: temperature: 30±3°C, cycle: 48±2 hours, shaking speed 220±20rpm;
[0017] Wherein, the culture conditions of the seed tank in step S2 are: temperature: 30±3°C, cycle: 24±2 hours;
[0018] Wherein, the culture conditions of the fermentation tank in step S3 are: temperature: 30±3°C, cycle: 190±10 hours;
[0019] In step S3, the fermenter is cultured until the amount of nucleic acid in the fermenter reaches 0.4 g / L or more, and the tylosin purified solution obtained in step (1) is added to the fermenter by a feeding method, and the flow rate needs to maintain 5 μg / mL≤butyl acetate residue≤21 μg / mL, and 12 μg / mL≤acetic acid+butanol residue≤35 μg / mL in the fermentation broth.
[0020] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0021] 1. The present invention uses the tylosin filtrate purified by butyl acetate extraction to replace the tylosin finished product for tylosin fermentation. The tylosin filtrate purified by butyl acetate extraction has a component of more than 90% and a content of more than 200,000 ug / mL, which can optimally meet the needs of tylosin fermentation and prepare high-quality tylosin. The present invention avoids using the tylosin finished product and reduces the complexity of dissolving the tylosin finished product in tylosin fermentation.
[0022] 2. The present invention controls the residual organic solvent in the tylosin filtrate to obtain a tylosin refined liquid, which is used for tylosin fermentation, and can increase the final potency of tylosin fermentation to more than 35000 μg / mL. Tylosin is an extracellular product. The appropriate content of organic solvent can increase the permeability of the cell membrane, which is beneficial to the cell's utilization of effective substances in the fermentation liquid and the secretion of products. The control and sterilization of the residual organic solvent, on the premise of improving the permeability of the cell membrane, prevents the residual organic solvent from being too high, exceeding the tolerance of the strain, causing the impact on the conversion ability or even apoptosis, and controls the whole process to be aseptic to prevent the lack of nutrients in the fermentation liquid caused by bacterial contamination during the fermentation process. The products of miscellaneous bacteria will change the environment in the fermentation tank and affect the conversion of tylosin.
[0023] 3. The present invention uses a tylosin refined solution containing a low concentration of organic solvent in the tylosin fermentation, and its fermentation level is increased by more than 3000 μg / mL compared with the fermentation level using the tylosin finished product, which provides a new idea for the joint production of tylosin and tylosin, and can effectively reduce the production cost. DETAILED DESCRIPTION
[0024] The technical solution of the present invention will be described clearly and completely by way of embodiments below. Based on the examples in the present invention, all other embodiments obtained by ordinary technicians in the field without creative work are within the scope of protection of the present invention.
[0025] Unless otherwise specified, the experimental methods used in the following examples are all commonly used methods in fermentation experiments.
[0026] Example 1 Tylosin filtrate is not subjected to refining treatment
[0027] 1. Obtain tylosin filtrate purified by butyl acetate extraction, with a tylosin content of 209121ug / mL and a component of 92.36%. Gas chromatography detected butyl acetate residue of 626μg / mL and acetic acid + butanol residue of 933.8μg / mL. Sterilize by 0.22μm filter membrane for later use.
[0028] 2. The strain producing tyvalosin was inoculated into the seed solution of the shake flask for cultivation. The strain came from the strain room of Hubei Huisheng Biotechnology Co., Ltd., and the strain collection number is CCTCC NO: M2010261, its culture conditions are: temperature: 30±3℃, cycle: 48±2 hours, shaking table speed 220±20rpm; the cultured shake flask seed liquid is inoculated into the seed tank culture medium for culture, and its culture conditions are: temperature: 30±3℃, cycle: 24±2 hours, tank pressure: 0.02~0.06MPa, air flow: 8L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, and there are no foreign bacteria; the seed culture medium in the cultured seed tank is inoculated into the fermentation tank for culture, and its culture conditions are: temperature: 30±3℃, cycle: 190±10 hours, tank pressure: 0.02~0.06MPa, air flow: 30L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, the minimum speed in the later stage is 200rpm, and there are no foreign bacteria.
[0029] 3. At 26h of the fermentation cycle in the fermenter, the biomass of the fermenter was tested to meet the conversion requirements. The nucleic acid value was 0.564g / L. The tylosin filtrate obtained in step 1 was supplied to the fermenter at a fixed rate of 20mL / h, and samples were taken for tylosin content testing.
[0030] The fermentation cycle was 184 hours, the tank volume was 45L, and the final tank titer was 28754μg / mL.
[0031] Example 2 Tylosin filtrate is refined
[0032] 1. Obtain the tylosin filtrate purified by butyl acetate extraction, with a tylosin content of 209846ug / mL and a component of 92.34%. The butyl acetate residue was 567.8μg / mL and the acetic acid + butanol residue was 873.7μg / mL after gas chromatography. Sterile air was introduced for purging, and the filtrate temperature was controlled to be maintained at 0-6°C for purging for 3 hours, and then the temperature was raised to 20°C for purging for 3 hours, and the filtrate temperature was controlled to be maintained at 20°C. The membrane surface flow rate was 1.5m / s and the activated carbon filter element was used for filtration. The butyl acetate residue was 243.7μg / mL and the acetic acid + butanol residue was 417.3μg / mL. Then, the tylosin refined solution was obtained for standby use. After the water bath, the butyl acetate residue was 144.3μg / mL and the acetic acid + butanol residue was 417.3μg / mL.
[0033] 2. The strain producing tyvalosin was inoculated into the seed solution of the shake flask for cultivation. The strain came from the strain room of Hubei Huisheng Biotechnology Co., Ltd., and the strain collection number is CCTCC NO: M2010261, its culture conditions are: temperature: 30±3℃, cycle: 48±2 hours, shaking table speed 220±20rpm; the cultured shake flask seed liquid is inoculated into the seed tank culture medium for culture, and its culture conditions are: temperature: 30±3℃, cycle: 24±2 hours, tank pressure: 0.02~0.06MPa, air flow: 8L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, and there are no foreign bacteria; the seed culture medium in the cultured seed tank is inoculated into the fermentation tank for culture, and its culture conditions are: temperature: 30±3℃, cycle: 190±10 hours, tank pressure: 0.02~0.06MPa, air flow: 30L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, the minimum speed in the later stage is 200rpm, and there are no foreign bacteria.
[0034] 3. When the fermentation cycle of the fermenter was 28h, the biomass of the fermenter was tested to meet the conversion requirements. The nucleic acid value was 0.562g / L. The tylosin refined solution obtained in step 1 was supplied to the fermenter at a fixed rate of 20mL / h, and samples were taken for tylosin content detection.
[0035] The fermentation cycle was 184 hours, the tank volume was 45L, and the final tank titer was 35363μg / mL.
[0036] Example 3 Tylosin filtrate is refined
[0037] 1. Obtain tylosin filtrate purified by butyl acetate extraction, tylosin content 207462ug / mL, components 91.76%, butyl acetate residue 601.8μg / mL, acetic acid + butanol residue 936.1μg / mL detected by gas chromatography. Sterile air is passed through to purge, the filtrate temperature is controlled to be maintained at 0-6°C for 3 hours, then the temperature is raised to 20°C for 3 hours, the filtrate temperature is controlled to be maintained at 20°C, the membrane surface flow rate is 1.5m / s, and an activated carbon filter element is used for filtration, and butyl acetate residue is measured to be 295.6μg / mL, acetic acid + butanol residue is 433.9μg / mL, and 0.22μm filter membrane is used for sterilization to obtain tylosin refined liquid for standby use.
[0038] 2. The strain producing tyvalosin was inoculated into the seed solution of the shake flask for cultivation. The strain came from the strain room of Hubei Huisheng Biotechnology Co., Ltd., and the strain collection number is CCTCC NO: M2010261, its culture conditions are: temperature: 30±3℃, cycle: 48±2 hours, shaking table speed 220±20rpm; the cultured shake flask seed liquid is inoculated into the seed tank culture medium for culture, and its culture conditions are: temperature: 30±3℃, cycle: 24±2 hours, tank pressure: 0.02~0.06MPa, air flow: 8L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, and there are no foreign bacteria; the seed culture medium in the cultured seed tank is inoculated into the fermentation tank for culture, and its culture conditions are: temperature: 30±3℃, cycle: 190±10 hours, tank pressure: 0.02~0.06MPa, air flow: 30L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, the minimum speed in the later stage is 200rpm, and there are no foreign bacteria.
[0039] 3. When the fermentation cycle of the fermenter is 28h, the biomass of the fermenter meets the conversion requirements. The nucleic acid value is 0.556g / L. The tylosin refined solution obtained in step 1 is supplied to the fermenter at a fixed rate of 20mL / h, and samples are taken for tylosin content detection.
[0040] The fermentation cycle was 183 hours, the tank volume was 45L, and the final tank titer was 36072μg / mL.
[0041] Example 4 Using Tylosin Powder for Tylosin Fermentation
[0042] 1. Use sterile water to dissolve tylosin powder in a clean bench. The tylosin powder comes from Workshop 305 of Hubei Huisheng Biotechnology Co., Ltd., and finally dissolve to obtain a tylosin solution with a tylosin content of 205371ug / mL and a component of 93.24%. The gas chromatography detected that the butyl acetate residue was 3μg / mL and the acetic acid + butanol residue was 26μg / mL, which was set aside.
[0043] 2. The strain producing tyvalosin was inoculated into the seed solution of the shake flask for cultivation. The strain came from the strain room of Hubei Huisheng Biotechnology Co., Ltd., and the strain collection number is CCTCC NO: M2010261, its culture conditions are: temperature: 30±3℃, cycle: 48±2 hours, shaking table speed 220±20rpm; the cultured shake flask seed liquid is inoculated into the seed tank culture medium for culture, and its culture conditions are: temperature: 30±3℃, cycle: 24±2 hours, tank pressure: 0.02~0.06MPa, air flow: 8L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, and there are no foreign bacteria; the seed culture medium in the cultured seed tank is inoculated into the fermentation tank for culture, and its culture conditions are: temperature: 30±3℃, cycle: 190±10 hours, tank pressure: 0.02~0.06MPa, air flow: 30L / min, initial speed 200rpm, the dissolved oxygen is maintained at 20%~30% by controlling the speed, the minimum speed in the later stage is 200rpm, and there are no foreign bacteria.
[0044] 3. When the fermentation cycle of the fermenter was 28h, the biomass of the fermenter was tested to meet the conversion requirements. The nucleic acid value was 0.558g / L. The tylosin solution obtained in step 1 was supplied to the fermenter at a fixed rate of 20mL / h, and samples were taken for tylosin content detection.
[0045] The fermentation cycle was 184 hours, the tank volume was 45L, and the final tank titer was 32176μg / mL.
[0046] From the comparison among Examples 2, 3 and 4, it can be seen that the fermentation level of tylosin refined liquid used in tylosin fermentation is significantly better than that of tylosin powder used in tylosin fermentation.
Claims
1. A method for using tylosin refined solution in tylosin fermentation, It is characterized in that The method comprises the following steps: adding tylosin refined liquid to a tylosin fermentation tank, and the preparation method of the tylosin refined liquid comprises: The tylosin filtrate was obtained, and after extraction and purification with butyl acetate, the residual organic solvent in the tylosin filtrate was controlled to meet the requirements: 100 μg / mL≤butyl acetate residue≤300 μg / mL, 200 μg / mL≤acetic acid+butanol residue≤500 μg / mL, and then sterilized to obtain tylosin refined solution.
2. The method according to claim 1, It is characterized in that When the amount of nucleic acid in the fermentation tank reaches 0.4 g / L or more, the tylosin refined solution is added to the tylosin fermentation tank by a feeding method. Preferably, the flow rate is maintained at 5 μg / mL≤butyl acetate residue≤21 μg / mL, and 12 μg / mL≤acetic acid+butanol residue≤35 μg / mL in the fermentation broth.
3. The method according to claim 1, It is characterized in that After the tylosin filtrate is extracted and purified by butyl acetate, the tylosin component reaches more than 90% and the content reaches more than 200000ug / mL.
4. The method according to claim 1, It is characterized in that Sterile air is introduced for purging, and activated carbon filter is used for filtration to control the residual organic solvent in the tylosin filtrate to meet the requirements.
5. The method according to claim 4, It is characterized in that The specific method of blowing in sterile air is: controlling the temperature of the filtrate to maintain at 0-6°C for 3 hours, then raising the temperature to 20°C for 3 hours, and / or The specific steps of filtering with activated carbon filter element are as follows: the filtrate temperature is controlled to be maintained at 20°C, and the membrane surface flow rate is 1.5m / s, and the activated carbon filter element is used for filtering.
6. The method according to claim 1, It is characterized in that The sterilization process is to use membrane filtration or water bath heating, the pore size of the filter membrane is ≤0.22μm, the water bath temperature is ≥80℃, and the insulation time is ≥30 minutes.
7. The method according to any one of claims 1 to 6, It is characterized in that The method comprises the following steps: S1: culturing seeds in a shake flask: inoculating a tylosin-producing strain into a shake flask seed solution for culturing; S2: culturing in a seed tank: inoculating the cultured shake flask seed solution into a seed tank culture medium for culturing; S3: culturing in a fermenter: inoculating the cultured seed culture medium in the seed tank into a fermenter for culturing, culturing until the biomass in the fermenter reaches the conversion requirement, and adding the tylosin refined solution in any one of the methods described in claims 1 to 6 to the fermenter to replace the tylosin finished product for conversion in the tylosin strain fermentation.
8. The method according to claim 7, It is characterized in that In step S3, the fermenter is cultured until the amount of nucleic acid reaches 0.4 g / L or more, and the tylosin refined solution is added to the fermenter by a feeding method. Preferably, the flow rate is maintained at 5 μg / mL≤butyl acetate residue≤21 μg / mL, and 12 μg / mL≤acetic acid+butanol residue≤35 μg / mL in the fermentation broth.
9. The method according to claim 7, It is characterized in that Step S1: The culture conditions of the shaking bottle seeds are as follows: temperature: 30±3°C, cycle: 48±2 hours, shaking speed 220±20rpm; Step S2: The culture conditions of the seed tank are: temperature: 30±3°C, cycle: 24±2 hours; The culture conditions of the fermentation tank in step S3 are: temperature: 30±3°C, cycle: 190±10 hours.
10. The method according to claim 7, It is characterized in that The final potency of tyvalocin fermentation was above 35000 μg / mL.
